A Clinical Study of TQB3824 in Subjects With Advanced Cancer
Clinical trial NCT05028218 · UNKNOWN
Trial details
- NCT number
- NCT05028218
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2024-08-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.